COLL Collegium Pharmaceutical, Inc.
$21.88 +0.05%
US Stock · Health Care
RSI (14) · 30 / 70 bands
MACD (12, 26, 9)
Solid = close · dashed = 50-day MA · bars = volume. Toggle Bollinger / RSI / MACD. Hover to inspect. EOD data.
1D
+0.05%
YTD
-34.50%
P/E
15.02
P/B
4.85
ROE
16%
Div yield
—
Beta
0.38
Market cap
$720M
RSI (14)
30
Next earnings
Nov 4, 2026
Previous session
close of Oct 6, 2026 · EOD, no live order bookOpen
$22.06
Close
$21.88
VWAP (n/a)
—
Day high
$22.32
Day low
$21.68
Volume
634K
VWAP = daily turnover ÷ volume — the volume-weighted average, the closest EOD read on where trading actually clustered. A true order book is live-only and needs a broker feed. Turnover/VWAP available for MOEX listings.
Latest headlines
Collegium Launches "Start Talking ADHD" with Practical Support to Help Families Navigate Care, School and Everyday Life
Yahoo Finance · Oct 6
3 Value Stocks That Fall Short
Yahoo Finance · Sep 28
5 Revealing Analyst Questions From Collegium Pharmaceutical’s Q2 Earnings Call
Yahoo Finance · Aug 15
Collegium Pharmaceutical (COLL) Q2 2026 Earnings Call Transcript
Yahoo Finance · Aug 13
Collegium Announces $50 Million Accelerated Share Repurchase Program
Yahoo Finance · Aug 13
COLL Q2 Deep Dive: ADHD Expansion and Pain Business Headwinds Shape Guidance
Yahoo Finance · Aug 10
Headlines via Yahoo Finance · links open the source · not an endorsement.
Recent SEC filings
8-K Aug 13, 2026 View → 10-Q Aug 6, 2026 View → 8-K Aug 6, 2026 View → 8-K May 15, 2026 View → 8-K May 12, 2026 View →
Source: SEC EDGAR · opens the official filing.
Research & reports
External resources — availability and opinions are theirs, not ours.
This is reference data for your own analysis — not a recommendation to buy or sell COLL. Try it in the Lab to size a position and see the risk.